4//SEC Filing
RAPPAPORT ANDREW 4
Accession 0001209191-20-059526
CIK 0001750284other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 7:00 PM ET
Size
7.7 KB
Accession
0001209191-20-059526
Insider Transaction Report
Form 4
RAPPAPORT ANDREW
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-09-18+56,964→ 56,964 totalExercise: $4.82Exp: 2030-09-17→ Common Stock (56,964 underlying) - Award
Stock Option (Right to Buy)
2020-11-18+21,520→ 21,520 totalExercise: $19.00Exp: 2030-11-17→ Common Stock (21,520 underlying)
Footnotes (2)
- [F1]The shares subject to the option are fully vested.
- [F2]The shares subject to the option vest in a series of 12 successive equal monthy installments measured from June 1, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001162157
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 7:00 PM ET
- Size
- 7.7 KB